- Brands Logos
- Logo Templates
- Icons
- Vectors
- Font In Logos
- Blog
Sphere Fluidics is a biotechnology company that specializes in developing and commercializing innovative products and technologies for single-cell analysis and characterization. The company was founded in 2010 and is headquartered in Cambridge, United Kingdom.
Sphere Fluidics focuses on the development of microfluidic systems and associated products for applications in various fields, including biopharmaceutical discovery, synthetic biology, and personalized medicine. Their proprietary technology platform, known as picodroplet-based, allows for the manipulation and analysis of individual cells or molecules in picoliter-sized droplets.
The company's flagship product is the Cyto-Mine® System, a fully automated platform for high-throughput single-cell analysis and monoclonality assurance. This system enables researchers to screen and isolate individual cells or clones of interest from heterogeneous populations, facilitating faster and more efficient cell line development, antibody discovery, and cell therapy workflows.
In addition to their Cyto-Mine® System, Sphere Fluidics offers a range of consumables, reagents, and software solutions to support single-cell analysis applications. They collaborate with academic institutions, pharmaceutical companies, and research organizations to further advance the field of single-cell analysis and its applications.
